Laboratorios Richmond SACIF

Laboratorios Richmond SACIF Inventory

The Inventory of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 26.27 B ARS. In the previous year, Inventory was 16.71 B ARS — a change of 57.26% (higher).

Inventory

26.27 BARS

YoY

57.26%

Last updated:

Inventory of Laboratorios Richmond SACIF is 2024 26.27 B ARS. Inventory of Laboratorios Richmond SACIF was 2023 16.71 B ARS. It decreases by 57.26% higher compared to the previous year.

The Laboratorios Richmond SACIF Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2017
475.71 M ARS
Jan 1, 2018
816.27 M ARS
Jan 1, 2019
1.27 B ARS
Jan 1, 2020
2.86 B ARS
Jan 1, 2021
7.91 B ARS
Jan 1, 2022
5.55 B ARS
Jan 1, 2023
16.71 B ARS
Jan 1, 2024
26.27 B ARS
The Laboratorios Richmond SACIF Inventory history
YEARInventoryYoY
26.27 BARS+57.26%
16.71 BARS+200.79%
5.55 BARS-29.82%
7.91 BARS+176.62%
2.86 BARS+125.75%
1.27 BARS+55.26%
816.27 MARS+71.59%
475.71 MARS+150.65%
189.79 MARS+33.56%
142.10 MARS+50.05%
94.70 MARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Inventory of Laboratorios Richmond SACIF is 26.27 B ARS in 2024.

Inventory of Laboratorios Richmond SACIF changed from 16.71 B ARS to 26.27 B ARS, representing a 57.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's ARS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Laboratorios Richmond SACIF historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF